Calm Moms-V: a trauma-informed web program for pregnant Veterans

Adaptation and Examination of a Trauma-informed Intervention for Pregnant Veterans (CDA 22-135)

Not applicable Interventional VA Office of Research and Development · NCT06906185

This program tests whether Calm Moms-V, a web-based CBT program, can reduce anxiety, stress, and low mood in pregnant Veterans with a history of trauma.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment36 (estimated)
SexFemale
SponsorVA Office of Research and Development Federal
Locations1 site (New Orleans, Louisiana)
Trial IDNCT06906185 on ClinicalTrials.gov

What this trial studies

Calm Moms-V is a tailored online cognitive behavioral therapy program for pregnant Veterans with prior trauma exposure, delivered as four weekly sessions plus a booster near delivery. The intervention targets anxiety, stress, and low mood using evidence-based CBT techniques adapted for pregnancy and Veteran-specific concerns. Participants who meet symptom and trauma criteria and have internet access will be enrolled and compared with care as usual, with measures of symptoms, functioning, and engagement collected over the perinatal period. The study will also collect information about implementing Calm Moms-V at additional VA sites to inform wider rollout.

Who should consider this trial

Good fit: Pregnant Veterans in any trimester who endorse a DSM-5 Criterion A traumatic event, have elevated anxiety or depression symptoms, and can access the internet via smartphone, tablet, or computer are the ideal candidates.

Not a fit: Patients with active psychosis, uncontrolled bipolar disorder, a severe alcohol/substance use disorder, or acute suicidal ideation requiring immediate hospitalization, or those without internet/device access, may not benefit from this web program.

Why it matters

Potential benefit: If successful, Calm Moms-V could reduce anxiety, stress, and depressive symptoms during pregnancy and improve functioning and engagement with mental health care among pregnant Veterans.

How similar studies have performed: Other web-based and CBT interventions have reduced anxiety, stress, and mood symptoms, and the original Calm Moms program showed promise, but Calm Moms-V is a newer adaptation specifically for pregnant Veterans with limited prior testing.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnant (any trimester)
* Endorse a DSM-5-TR Criterion A traumatic event as indexed by the trauma exposure portion of the PTSD screen for primary care (PC-PTSD-5)
* Endorse clinically elevated anxiety (as indexed by a total score of \> 3 on the GAD-2) or depression symptoms (as indexed by a total score of \> 3 on the PHQ-2)
* Able to participate in an online intervention (i.e., have internet and smartphone, tablet, or computer access)

Of note, pregnant Veterans will still be eligible if they are in concurrent psychotherapy and/or using psychotropic medications.

Exclusion Criteria:

* Evidence of a significant mental illness that would impede completion of the intervention

  * (i.e., active psychosis, uncontrolled bipolar disorder, a severe alcohol/substance use disorder, or suicidal ideation or behavior that requires immediate hospitalization or treatment)

Evidence of a significant mental illness will be determined via pre-enrollment chart review.

Where this trial is running

New Orleans, Louisiana

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Trauma-related Mental Health SymptomsAnxietyDepressionPTSDPregnant VeteranReproductive Mental Health
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.